Date of publication: July 30, 2021 Decision of the Secretary of Health: Approved Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of continue reading : SARS-CoV-2 Vaccine (Vero Cell), Inactivated [CoronaVac] for the Prevention of COVID-19 (July Updates)
Two-dose Inactivated Polio Vaccine (IPV) versus One-dose IPV for the prevention of Poliomyelitis
Date of publication: July 13, 2021 Evidence Summary: Two-dose Inactivated Polio Vaccine (IPV) versus One- dose IPV for the prevention of Poliomyelitis Advisory for Appeals on Preliminary Recommendation: https://bit.ly/CallforAppeals_2DoseIPVPNF HTAC Recommendation Review:
Sputnik V, Pfizer – BioNTech, Janssen, AstraZeneca (June Reassessments)
COVID-19 VACCINES EVIDENCE SUMMARY HTAC PRESS RELEASE In fulfilment of its mandate of promoting evidence-informed health policy and decision-making, the Health Technology Assessment Council (HTAC) continues to update its assessments of health technologies. In light of emerging real world effectiveness and real world safety data, the HTAC considers new evidence in updating recommendations on the continue reading : Sputnik V, Pfizer – BioNTech, Janssen, AstraZeneca (June Reassessments)
COVID-19 mRNA Vaccine (Nucleoside Modified) (COVID-19 Vaccine Moderna) for the Prevention of COVID-19
Date of publication: May 28, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Vaccine Moderna. This assessment follows the continue reading : COVID-19 mRNA Vaccine (Nucleoside Modified) (COVID-19 Vaccine Moderna) for the Prevention of COVID-19
Use of RT-PCR Testing for COVID-19 (April 2021 Assessment)
Date of publication: April 30, 2021 Objectives: Evidence Summary: Use of RT-PCR Testing for COVID-19 HTAC Recommendation Review: